Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


Articles published in Can J Cardiol

Retrieve available abstracts of 83 articles:
HTML format



Single Articles


    March 2022
  1. PERRIN N, Avram R
    Invasive Management of Refractory Angina: Are We There Yet?
    Can J Cardiol. 2022;38:306-308.
    PubMed    


  2. HOCHSTADT A, Itach T, Merdler I, Ghantous E, et al
    Effectiveness of Coronary Sinus Reducer for Treatment of Refractory Angina: A Meta-analysis.
    Can J Cardiol. 2022;38:376-383.
    PubMed     Abstract available


  3. BOUCHER T, Shah AM, Hashim H, Jerschow E, et al
    Durable Polymer Drug Eluting Stent-Induced Kounis Syndrome and Eosinophilia Requiring Long-term Immunosuppression.
    Can J Cardiol. 2022;38:398-400.
    PubMed    


  4. EMAMI M, Agbaedeng TA, Thomas G, Middeldorp ME, et al
    Accelerated Biological Aging Secondary to Cardiometabolic Risk Factors Is a Predictor of Cardiovascular Mortality: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2022;38:365-375.
    PubMed     Abstract available


    February 2022
  5. MALHI N, Moghaddam N, Hosseini F, Singer J, et al
    Care and Outcomes of ST-Segment-Elevation Myocardial Infarction across multiple Coronavirus Disease 2019 (COVID-19) waves.
    Can J Cardiol. 2022 Feb 10. pii: S0828-282X(22)00089.
    PubMed     Abstract available


    January 2022
  6. BOITARD SE, Keck M, Deloux R, Girault-Sotias PE, et al
    QGC606, a best-in-class orally active centrally acting aminopeptidase A inhibitor prodrug, for treating heart failure following myocardial infarction.
    Can J Cardiol. 2022 Jan 25. pii: S0828-282X(22)00069.
    PubMed     Abstract available


  7. CHAVARRIA J, Sibbald M, Velianou J, Natarajan M, et al
    A Computed Tomography Protocol to Evaluate Coronary Artery Disease Before Transcatheter Aortic Valve Replacement.
    Can J Cardiol. 2022;38:23-30.
    PubMed     Abstract available


  8. TANG H, Li Z, Fan Y, Zhang T, et al
    Differences in Culprit Lesions Between Premenopausal and Postmenopausal Women With Acute Coronary Syndrome: An Optical Coherence Tomography Study.
    Can J Cardiol. 2022;38:85-91.
    PubMed     Abstract available


  9. LEBOUTTE PH, Demers P, Joubert P, Marquis-Gravel G, et al
    Percutaneous Management of Septic Left Anterior Descending Coronary Occlusion Following Minimally Invasive Surgery for Mitral Valve Infective Endocarditis.
    Can J Cardiol. 2022;38:126-128.
    PubMed     Abstract available


  10. GALLONE G, Baldetti L, Angelini F, Saglietto A, et al
    The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials.
    Can J Cardiol. 2022;38:113-122.
    PubMed     Abstract available


    December 2021
  11. DEL MONTE A, Marra MP, Cardaioli F, Gerosa G, et al
    Two left ventricular pseudoaneurysms complicating a myocardial infarction. The impact of cardiac magnetic resonance in the acute setting.
    Can J Cardiol. 2021 Dec 6. pii: S0828-282X(21)00918.
    PubMed     Abstract available


  12. SAMUEL R, Alfadhel M, McAlister C, Nestelberger T, et al
    Coronary Events in the Pregnant Patient: Who Is at Risk and How Best to Manage?
    Can J Cardiol. 2021;37:2026-2034.
    PubMed     Abstract available


  13. ZEN M, Marschner S, Szczeklik W, Roshanov PS, et al
    Association of Preeclampsia With Myocardial Injury Among Patients Undergoing Noncardiac Surgery: The PREECLAMPSIA-VISION Study.
    Can J Cardiol. 2021;37:1934-1941.
    PubMed     Abstract available


    November 2021
  14. LEE M, Lee K, Kim DW, Cho JS, et al
    Relationship of serial hsCRP changes to long-term clinical outcomes in stabilized post myocardial infarction patients.
    Can J Cardiol. 2021 Nov 1. pii: S0828-282X(21)00808.
    PubMed     Abstract available


  15. LEASURE M, Jain U, Butchy A, Otten J, et al
    Deep Learning Algorithm Predicts Angiographic Coronary Artery Disease in Stable Patients Using Only a Standard 12-Lead Electrocardiogram.
    Can J Cardiol. 2021;37:1715-1724.
    PubMed     Abstract available


  16. MARQUIS-GRAVEL G, Goodman SG, Anderson TJ, Bell AD, et al
    Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians.
    Can J Cardiol. 2021;37:1837-1845.
    PubMed     Abstract available


  17. MURAI K, Otsuka F, Yoneda S, Kataoka Y, et al
    Temporal Changes in Near-Infrared Spectroscopy Signals in Recurrent In-Stent Restenosis Attributable to Calcified Nodule.
    Can J Cardiol. 2021;37:1880-1881.
    PubMed    


    October 2021
  18. BLUSZTEIN D, Teng P, Deuse T, Mahadevan VS, et al
    Shock, Thrombus, TAVR: A Challenging TAVR With Large Left-Ventricular Thrombus.
    Can J Cardiol. 2021;37:1668-1670.
    PubMed     Abstract available


  19. GOSLING RC, Adam Z, Barmby DS, Iqbal J, et al
    The Impact of Virtual Fractional Flow Reserve and Virtual Coronary Intervention on Treatment Decisions in the Cardiac Catheter Laboratory.
    Can J Cardiol. 2021;37:1530-1538.
    PubMed     Abstract available


  20. KOO CY, Lim AYN, Chan KH
    Recurrent Stent Thrombosis Secondary to Immunoglobulin G4-Related Disease.
    Can J Cardiol. 2021;37:1659-1660.
    PubMed     Abstract available


  21. LUO T, Liu H, Chen B, Liu H, et al
    A Novel Role of Claudin-5 in Prevention of Mitochondrial Fission Against Ischemic/Hypoxic Stress in Cardiomyocytes.
    Can J Cardiol. 2021;37:1593-1606.
    PubMed     Abstract available


  22. JOLICOEUR EM, Pelletier-Galarneau M
    Rubidium-82 Positron Emission Tomography With Intravenous Ergonovine to Diagnose Vasospastic Angina.
    Can J Cardiol. 2021;37:1661-1664.
    PubMed     Abstract available


    September 2021
  23. CHEW NWS, Ow ZGW, Teo VXY, Heng RRY, et al
    The Global Effect of the COVID-19 Pandemic on STEMI Care: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2021;37:1450-1459.
    PubMed     Abstract available


  24. MASTERSON CREBER R, Spadaccio C, Dimagli A, Myers A, et al
    Patient-Reported Outcomes in Cardiovascular Trials.
    Can J Cardiol. 2021;37:1340-1352.
    PubMed     Abstract available


    August 2021
  25. VIKULOVA DN, Trinder M, Mancini GBJ, Pimstone SN, et al
    Familial Hypercholesterolemia, Familial Combined Hyperlipidemia and Elevated Lipoprotein(a) in Patients with Premature Coronary Artery Disease.
    Can J Cardiol. 2021 Aug 26. pii: S0828-282X(21)00657.
    PubMed     Abstract available


  26. PATERSON I, Ramanathan K, Aurora R, Bewick D, et al
    Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team.
    Can J Cardiol. 2021;37:1260-1262.
    PubMed     Abstract available


  27. ROSHANOV PS, Sessler DI, Chow CK, Garg AX, et al
    Predicting Myocardial Injury and Other Cardiac Complications After Elective Noncardiac Surgery with the Revised Cardiac Risk Index: The VISION Study.
    Can J Cardiol. 2021;37:1215-1224.
    PubMed     Abstract available


  28. MARIUCCI E, Bonori L, Lovato L, Graziano C, et al
    Coronary Artery Aneurysms in Patients With Marfan Syndrome: Frequent, Progressive, and Relevant.
    Can J Cardiol. 2021;37:1225-1231.
    PubMed     Abstract available


  29. CHIU S, Nayak R, Lin B, Duan L, et al
    Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome.
    Can J Cardiol. 2021;37:1191-1197.
    PubMed     Abstract available


  30. ABOUKHOUDIR F, Najjar A, Moussa K, Habib G, et al
    A Thrombus on a Journey: A Massive Thrombus in Transit With Cerebral, Coronary, and Pulmonary Embolization.
    Can J Cardiol. 2021;37:1281-1282.
    PubMed     Abstract available


    July 2021
  31. HADJADJ S, Marsit O, Paradis JM, Beaudoin J, et al
    Pathophysiology, Diagnosis, and New Therapeutic Approaches for Ischemic Mitral Regurgitation.
    Can J Cardiol. 2021;37:968-979.
    PubMed     Abstract available


    June 2021
  32. XIE Y, Seidman MA
    Inflammatory Comments in Coronary Artery Disease: When to Suspect Polyarteritis Nodosa or Other Primary Systemic Vasculitis.
    Can J Cardiol. 2021;37:830-832.
    PubMed    


  33. LAI J, Zhao L, Zhong H, Zhou J, et al
    Characteristics and Outcomes of Coronary Artery Involvement in Polyarteritis Nodosa.
    Can J Cardiol. 2021;37:895-903.
    PubMed     Abstract available


  34. MA K, Qi L, Yuan J, Zhang B, et al
    Anatomic Repair of Left Main Coronary Artery Atresia: Coronary Ostioplasty With Autologous Pulmonary Artery.
    Can J Cardiol. 2021;37:887-894.
    PubMed     Abstract available


    May 2021
  35. LIAUW SS, Luong L, Liu S, Atcha M, et al
    Clinical Presentation and Outcome of Patients Experiencing Homelessness Presenting with ST-Elevation Myocardial Infarction.
    Can J Cardiol. 2021 May 15. pii: S0828-282X(21)00247.
    PubMed     Abstract available


    April 2021
  36. ALY S, Aguet J, Dragulescu A, Grosse-Wortmann L, et al
    Neonatal Myocardial Infarction in Association with Gestational Diabetes.
    Can J Cardiol. 2021 Apr 17. pii: S0828-282X(21)00211.
    PubMed     Abstract available


  37. WELSH RC, Cantor WJ, Traboulsi M, Schampaert E, et al
    Primary Percutaneous Coronary Intervention and Application of the Pharmacoinvasive Approach Within ST-Elevation Myocardial Infarction Care Networks: CJC Supplement - 40 Years of Innovation in Interventional Cardiology in Canada.
    Can J Cardiol. 2021 Apr 7. pii: S0828-282X(21)00173.
    PubMed     Abstract available


  38. MCDONALD M, Virani S, Chan M, Ducharme A, et al
    CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.
    Can J Cardiol. 2021;37:531-546.
    PubMed     Abstract available


  39. YANG W, Zhang A, Han Y, Su X, et al
    Cyclin-Dependent Kinase Inhibitor 2b Controls Fibrosis and Functional Changes in Ischemia-Induced Heart Failure via the BMI1-p15-Rb Signalling Pathway.
    Can J Cardiol. 2021;37:655-664.
    PubMed     Abstract available


    March 2021
  40. CHO SM, Austin PC, Ross HJ, Abdel-Qadir H, et al
    MACHINE LEARNING COMPARED TO CONVENTIONAL STATISTICAL MODELS FOR PREDICTING MYOCARDIAL INFARCTION READMISSION AND MORTALITY: A SYSTEMATIC REVIEW.
    Can J Cardiol. 2021 Mar 4. pii: S0828-282X(21)00129.
    PubMed     Abstract available


  41. KAVSAK PA, Mondoux S, Worster A, Martin J, et al
    Misclassification of Myocardial Injury by a High-Sensitivity Cardiac Troponin I Assay.
    Can J Cardiol. 2021;37:523.
    PubMed    


  42. YOON YH, Lee PH, Park TK, Lee JH, et al
    Technical Feasibility and Safety of Percutaneous Coronary Intervention for True Ostial Left Anterior Descending Artery-Chronic Total Occlusion.
    Can J Cardiol. 2021;37:458-466.
    PubMed     Abstract available


  43. GRAVEL H, Behzadi P, Cardinal S, Barry H, et al
    Acute Vascular Benefits of Finnish Sauna Bathing in Patients With Stable Coronary Artery Disease.
    Can J Cardiol. 2021;37:493-499.
    PubMed     Abstract available


    February 2021
  44. HILLANI A, Potter BJ
    Intracoronary Thrombus and No-Reflow: One Size to Fit All?
    Can J Cardiol. 2021;37:202-205.
    PubMed    


  45. NGUYEN CH, Marzolini S, Oh P, Thomas SG, et al
    A Retrospective Comparison of Fitness and Exercise Progression in Patients With Coronary and Peripheral Artery Disease in Cardiac Rehabilitation.
    Can J Cardiol. 2021;37:260-268.
    PubMed     Abstract available


  46. SEMSAR-KAZEROONI K, Dima D, Valiquette J, Berube-Dufour J, et al
    Early Mobilization in People With Acute Cardiovascular Disease.
    Can J Cardiol. 2021;37:232-240.
    PubMed     Abstract available


  47. ALYAMANI M, Campbell S, Navarese E, Welsh RC, et al
    Safety and Efficacy of Intracoronary Thrombolysis as Adjunctive Therapy to Primary PCI in STEMI: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2021;37:339-346.
    PubMed     Abstract available


    January 2021
  48. LAVIE CJ, Ozemek C, Grace SL
    More Evidence of Comprehensive Cardiac Rehabilitation Benefits, Even for All-Cause Mortality: Need to Increase Use Worldwide.
    Can J Cardiol. 2021;37:19-21.
    PubMed    


  49. GOUDA P, Wang X, McGillion M, Graham MM, et al
    Underutilization of Perioperative Screening for Cardiovascular Events After Noncardiac Surgery in Alberta.
    Can J Cardiol. 2021;37:57-65.
    PubMed     Abstract available


  50. YANG X, Du X, Ma K, Li G, et al
    Circulating miRNAs Related to Long-term Adverse Cardiovascular Events in STEMI Patients: A Nested Case-Control Study.
    Can J Cardiol. 2021;37:77-85.
    PubMed     Abstract available


  51. HUANG R, Palmer SC, Cao Y, Zhang H, et al
    Cardiac Rehabilitation Programs for Chronic Heart Disease: A Bayesian Network Meta-analysis.
    Can J Cardiol. 2021;37:162-171.
    PubMed     Abstract available


  52. BOHM P, Scharhag J, Egger F, Tischer KH, et al
    Sports-Related Sudden Cardiac Arrest in Germany.
    Can J Cardiol. 2021;37:105-112.
    PubMed     Abstract available


  53. GAO C, Buszman P, Buszman P, Chichareon P, et al
    Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial.
    Can J Cardiol. 2021;37:122-130.
    PubMed     Abstract available


    December 2020
  54. FARDMAN A, Oren D, Beigel R, Matetzky S, et al
    Reply to Culic et al: Covid-19 pandemic and possible rebound phenomenon in incidence of acute myocardial infarction.
    Can J Cardiol. 2020 Dec 13. pii: S0828-282X(20)31142.
    PubMed    


    November 2020
  55. CULIC V, AlTurki A, Proietti R
    Covid-19 pandemic and possible rebound phenomenon in incidence of acute myocardial infarction.
    Can J Cardiol. 2020 Nov 16. pii: S0828-282X(20)31105.
    PubMed    


  56. MARBACH JA, Alhassani S, Chong AY, MacPhee E, et al
    A Novel Protocol for Very Early Hospital Discharge After STEMI.
    Can J Cardiol. 2020;36:1826-1829.
    PubMed     Abstract available


    June 2020
  57. SCOTT L JR, Li N
    From Neutrophil Calcium Sensor to Myocardial Remodelling-A Double-Edged Pathway Guided by the Inflammasome.
    Can J Cardiol. 2020;36:813-815.
    PubMed    


  58. LIU Y, Lu C, Guo Q
    Recurrent Type III Kounis Syndrome: Will Anti-Immunoglobulin E Drug Be Another Option?
    Can J Cardiol. 2020;36:966.
    PubMed     Abstract available


  59. RIKU S, Suzuki S, Jinno Y, Tanaka A, et al
    Coronary Drug-Eluting Stent Infection Complicated by Coronary Artery Aneurysm and Purulent Pericarditis: Complete Resolution Without Surgery.
    Can J Cardiol. 2020;36:967.
    PubMed     Abstract available


  60. NAM MCY, Di Marco A, Ausami A, Markham H, et al
    Demarcation of Transient Regional Myocardial Edema in Endocrinopathy-Induced Takotsubo Cardiomyopathy on Cardiac Magnetic Resonance T1 Mapping.
    Can J Cardiol. 2020;36:968.
    PubMed    


  61. MOULIN S, Thomas A, Arnaud C, Arzt M, et al
    Cooperation Between Hypoxia-Inducible Factor 1alpha and Activating Transcription Factor 4 in Sleep Apnea-Mediated Myocardial Injury.
    Can J Cardiol. 2020;36:936-940.
    PubMed     Abstract available


  62. SCARPARO P, Wilschut J, Van Mieghem NM, Diletti R, et al
    Management of Septal Branch Perforation and Septal Hematoma During Retrograde Treatment of Coronary Chronic Total Occlusion Using Fat Embolization.
    Can J Cardiol. 2020;36:966.
    PubMed     Abstract available


  63. FAN L, Lucking AJ, Kelion A, Sabharwal N, et al
    Aortic Pseudoaneurysm With Compression of Left Main Stem Following Aortic Valve Replacement.
    Can J Cardiol. 2020;36:968.
    PubMed    


  64. WATERS DD
    Notes From the Cardiology Clinic: Facing Down the Dragons of Health Anxiety.
    Can J Cardiol. 2020;36:820-821.
    PubMed    


  65. SANTORO G, Salerno G, Cappelli Bigazzi M, Golino P, et al
    Challenging Transcatheter Treatment of a "Complex" Refractory Congestive Heart Failure.
    Can J Cardiol. 2020;36:968.
    PubMed    


  66. SATTLER K, El-Battrawy I, Gietzen T, Kummer M, et al
    Improved Outcome of Cardiogenic Shock Triggered by Takotsubo Syndrome Compared With Myocardial Infarction.
    Can J Cardiol. 2020;36:860-867.
    PubMed     Abstract available


  67. RASHID M, Kontopantelis E, Kinnaird T, Curzen N, et al
    Association Between Hospital Cardiac Catheter Laboratory Status, Use of an Invasive Strategy, and Outcomes After NSTEMI.
    Can J Cardiol. 2020;36:868-877.
    PubMed     Abstract available


  68. MORRIS PD, Gosling R, Rothman A, Iqbal J, et al
    Double-Kissing Nanocrush for Bifurcation Lesions: Development, Bioengineering, Fluid Dynamics, and Initial Clinical Testing.
    Can J Cardiol. 2020;36:852-859.
    PubMed     Abstract available


  69. CRIMI G, Mandurino-Mirizzi A, Gritti V, Scotti V, et al
    Percutaneous Coronary Intervention Techniques for Bifurcation Disease: Network Meta-analysis Reveals Superiority of Double-Kissing Crush.
    Can J Cardiol. 2020;36:906-914.
    PubMed     Abstract available


    May 2020
  70. MARC Y, Boitard SE, Balavoine F, Azizi M, et al
    Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure.
    Can J Cardiol. 2020;36:721-731.
    PubMed     Abstract available


  71. FELDMAN RD
    Sex-Specific Determinants of Coronary Artery Disease and Atherosclerotic Risk Factors: Estrogen and Beyond.
    Can J Cardiol. 2020;36:706-711.
    PubMed     Abstract available


  72. BLAIS C, Rochette L, Ouellet S, Huynh T, et al
    Complex Evolution of Epidemiology of Vascular Diseases, Including Increased Disease Burden: From 2000 to 2015.
    Can J Cardiol. 2020;36:740-746.
    PubMed     Abstract available


  73. DE FARIA AP, Modolo R, Chichareon P, Chang CC, et al
    Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS.
    Can J Cardiol. 2020;36:747-755.
    PubMed     Abstract available


    April 2020
  74. KIMURA Y, Kondo T, Mutsuga M, Morimoto R, et al
    Impella 5.0 for Cardiogenic Shock After Thrombectomy in a Patient With Intraventricular Thrombosis.
    Can J Cardiol. 2020 Apr 11. pii: S0828-282X(20)30327.
    PubMed     Abstract available


  75. BEN-SHOSHAN J, Banai S
    Coronary Sinus Reducer and Left Ventricular Function.
    Can J Cardiol. 2020;36:474-475.
    PubMed    


  76. ALHUMAID W, Paterson DI
    Drug-Induced Acute Coronary Syndrome: A New Cardiovascular Concern With Immune Checkpoint Inhibitors and the Need for a Prospective Registry.
    Can J Cardiol. 2020;36:455-456.
    PubMed    


  77. MILLER DD
    Machine Intelligence for Management of Acute Coronary Syndromes: Neural or Nervous Times?
    Can J Cardiol. 2020;36:470-473.
    PubMed    


  78. ZHANG YJ, Chen Y, Zhao X, Chang X, et al
    Coronary Arteritis and Periaortitis in IgG4-Related Disease.
    Can J Cardiol. 2020;36:589.
    PubMed     Abstract available


  79. IANNATTONE PA, Zhao X, VanHouten J, Garg A, et al
    Artificial Intelligence for Diagnosis of Acute Coronary Syndromes: A Meta-analysis of Machine Learning Approaches.
    Can J Cardiol. 2020;36:577-583.
    PubMed     Abstract available


  80. LI Z, Habbous S, Thain J, Hall DE, et al
    Cost-Effectiveness Analysis of Frailty Assessment in Older Patients Undergoing Coronary Artery Bypass Grafting Surgery.
    Can J Cardiol. 2020;36:490-499.
    PubMed     Abstract available


  81. GALLONE G, Palmisano A, Baldetti L, Monti CB, et al
    Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction.
    Can J Cardiol. 2020;36:589.
    PubMed     Abstract available


  82. CAUTELA J, Rouby F, Salem JE, Alexandre J, et al
    Acute Coronary Syndrome With Immune Checkpoint Inhibitors: A Proof-of-Concept Case and Pharmacovigilance Analysis of a Life-Threatening Adverse Event.
    Can J Cardiol. 2020;36:476-481.
    PubMed     Abstract available


  83. LEI C, Huang Y, Yuan S, Chen W, et al
    Takayasu Arteritis With Coronary Artery Involvement: Differences Between Pediatric and Adult Patients.
    Can J Cardiol. 2020;36:535-542.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: